Baidu
map

郭艺芳:解读非心脏手术围术期心血管评估与管理指南

2014-08-05 河北省人民医院 郭艺芳 石立勋 医学论坛网

8月1日,《循环》(Circulation)杂志在线发布了2014年《ACC/AHA非心脏手术患者围术期心血管评估和管理指南》及执行摘要、《2014ACC/AHA系统回顾:β阻滞剂在非心脏手术围术期患者中的应用》。指南下载:欧美同期发布新版非心脏手术患者围术期心血管评估和管理指南 郭艺芳教授对ACC/AHA非心脏手术患者围术期心血管评估和管理指南进行了解读,以下为详细内容。

8月1日,《循环》(Circulation)杂志在线发布了2014年《ACC/AHA非心脏手术患者围术期心血管评估和管理指南》及执行摘要、《2014ACC/AHA系统回顾:β阻滞剂在非心脏手术围术期患者中的应用》。

指南下载:欧美同期发布新版非心脏手术患者围术期心血管评估和管理指南

郭艺芳教授对ACC/AHA非心脏手术患者围术期心血管评估和管理指南进行了解读,以下为详细内容。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1936275, encodeId=262419362e5e9, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Mon Sep 01 11:21:00 CST 2014, time=2014-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819247, encodeId=d8ef181924eb3, content=<a href='/topic/show?id=aba89940943' target=_blank style='color:#2F92EE;'>#非心脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99409, encryptionId=aba89940943, topicName=非心脏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Wed Aug 27 23:21:00 CST 2014, time=2014-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275361, encodeId=d71112e5361a9, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu Aug 07 02:21:00 CST 2014, time=2014-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488258, encodeId=7f75148825879, content=<a href='/topic/show?id=f37799413a6' target=_blank style='color:#2F92EE;'>#非心脏手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99413, encryptionId=f37799413a6, topicName=非心脏手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5438409695, createdName=bnurmamat, createdTime=Thu Aug 07 02:21:00 CST 2014, time=2014-08-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1936275, encodeId=262419362e5e9, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Mon Sep 01 11:21:00 CST 2014, time=2014-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819247, encodeId=d8ef181924eb3, content=<a href='/topic/show?id=aba89940943' target=_blank style='color:#2F92EE;'>#非心脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99409, encryptionId=aba89940943, topicName=非心脏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Wed Aug 27 23:21:00 CST 2014, time=2014-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275361, encodeId=d71112e5361a9, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu Aug 07 02:21:00 CST 2014, time=2014-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488258, encodeId=7f75148825879, content=<a href='/topic/show?id=f37799413a6' target=_blank style='color:#2F92EE;'>#非心脏手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99413, encryptionId=f37799413a6, topicName=非心脏手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5438409695, createdName=bnurmamat, createdTime=Thu Aug 07 02:21:00 CST 2014, time=2014-08-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1936275, encodeId=262419362e5e9, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Mon Sep 01 11:21:00 CST 2014, time=2014-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819247, encodeId=d8ef181924eb3, content=<a href='/topic/show?id=aba89940943' target=_blank style='color:#2F92EE;'>#非心脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99409, encryptionId=aba89940943, topicName=非心脏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Wed Aug 27 23:21:00 CST 2014, time=2014-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275361, encodeId=d71112e5361a9, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu Aug 07 02:21:00 CST 2014, time=2014-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488258, encodeId=7f75148825879, content=<a href='/topic/show?id=f37799413a6' target=_blank style='color:#2F92EE;'>#非心脏手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99413, encryptionId=f37799413a6, topicName=非心脏手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5438409695, createdName=bnurmamat, createdTime=Thu Aug 07 02:21:00 CST 2014, time=2014-08-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1936275, encodeId=262419362e5e9, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Mon Sep 01 11:21:00 CST 2014, time=2014-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819247, encodeId=d8ef181924eb3, content=<a href='/topic/show?id=aba89940943' target=_blank style='color:#2F92EE;'>#非心脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99409, encryptionId=aba89940943, topicName=非心脏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Wed Aug 27 23:21:00 CST 2014, time=2014-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275361, encodeId=d71112e5361a9, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu Aug 07 02:21:00 CST 2014, time=2014-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488258, encodeId=7f75148825879, content=<a href='/topic/show?id=f37799413a6' target=_blank style='color:#2F92EE;'>#非心脏手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99413, encryptionId=f37799413a6, topicName=非心脏手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5438409695, createdName=bnurmamat, createdTime=Thu Aug 07 02:21:00 CST 2014, time=2014-08-07, status=1, ipAttribution=)]

相关资讯

ACC 2014:早期静脉用β阻滞剂或可减少STEMI患者梗死面积

2014年美国心脏病学会年会(ACC 2014)公布的METOCARD-CNIC研究表明,在直接行经皮冠状动脉介入(PCI)治疗的ST段抬高性心肌梗死(STEMI)患者中,早期静脉应用β阻滞剂与5-7天时梗死面积减少有相关性,这进而改善了患者6个月时的左心室射血分数。虽然该研究的临床终点不够有力,但在美托洛尔组中,有不良心血管事件减少的有利趋势。 该随机平行分层研究纳入270例患者,平均年龄为5

ACC 2014:瑞舒伐他汀治疗儿童和青少年HeFH患者动脉壁的变化(CHARON研究)

    平均颈动脉内膜中层厚度(cIMT)是成人未来冠心病发生率的预测因素。已证实,瑞舒伐他汀在年龄为10~18岁的儿童和青少年中显著降低低密度脂蛋白胆固醇(LDL-C)水平。     CHARON研究纳入198例年龄为6~17岁的杂合子家族性高胆固醇血症(HeFH)儿童患者,患者空腹LDL-C>190mg/dl(>4.9 mmol/L)

ACC 2014:细数那些令我们难忘的研究

  刚刚过去的第63届美国心脏病学会(ACC)已然拉上大幕,但其中的焦点研究仍令人回味。对研究者及相关领域专家的采访实录,可以让我们全景式了解研究的始末和细节。1SYMPLICITY HTN-3研究  我积极推荐该领域的继续探索,但对向患者推荐去肾交感神经术(RDN)持非常谨慎和保守态度。  ——主要研究者之一、美国哈佛大学医学院布莱根妇女医院Bhatt教授  《论坛报》:作为介入科医生,在H

南方会:霍勇教授详解ACC 2014四大关键词

11日上午,第16届中国南方国际心血管病学术会议(南方会)举行了开幕式。在简短的开幕式后,本次会议的重头戏——心血管病临床国际论坛吸引了众多与会者。美国心脏病学会(ACC)年会刚刚结束,中华医学会心血管病学分会主任委员、北京大学第一医院霍勇教授通过回顾4项研究,总结了ACC2014的四大关键词:失望、希望、争议、共识。霍教授的总结无疑令广大医师对ACC2014学术内容的理解更加深刻。失望霍教授

ACC 2014:心梗患者直接PCI抗凝 肝素完胜比伐卢定

2014年美国心脏病学会科学年会上,英国的Adeel Shahzad博士(英国利物浦心胸医院)报告了HEAT-PPCI试验结果,该研究比较了急性心肌梗死PCI患者采用肝素与比卢伐定抗凝的临床疗效和安全性。结果肝素完胜比伐卢定,肝素组心梗复发和支架内血栓发生率更低。这让现场专家颇感意外并展开了激烈讨论,各方对研究结果及研究自身存在的问题发表了看法。HEAT-PPCI试验是一项单中心开放标签研究,共纳

OCC 2014:SYMPLICITY HTN-3研究失败,肾去神经消融术并未终结——访高血压论坛坛主高平进教授

记者:您能否谈谈肾去神经消融术在难治性高血压领域的治疗进展及前景?高平进教授:难治性高血压是一种特殊性高血压,其治疗也是热门话题之一。自从2009年国际上首次发表用肾去神经消融术(RDN)治疗难治性高血压以来,该技术曾经一度在国内外掀起热潮。但在今年3月底ACC会议公布了SYMPLICITY HTN-3的结果以后,RDN治疗高血压似乎跌入低谷。SYMPLICITY HTN-3是迄今为止国际上最

Baidu
map
Baidu
map
Baidu
map